Increased intestinal permeability is real, measurable physiology; "leaky gut syndrome" as a standalone diagnosis is not recognized by mainstream medicine. Both statements are true at once, and holding them together is the only way to make sense of this topic. The intestinal barrier is a single layer of cells sealed by tight junctions, and its permeability is dynamically regulated rather than fixed. Increased permeability is well documented in celiac disease, inflammatory bowel disease, regular NSAID use, heavy alcohol intake, critical illness and a subset of irritable bowel syndrome. What is not established is that a loosened barrier is the root cause of unexplained fatigue, brain fog or food reactions in an otherwise healthy person, or that any commercial test can confirm it. This article covers what the barrier is, what genuinely damages it, what the zonulin controversy involves, which tests report what, and a repair sequence that starts with diagnosis.
Free interactive tool
Gut barrier stressor check
Tick the exposures in your history to see what is known about each one's effect on the intestinal barrier and how strong that evidence is.
In this article
- What the intestinal barrier is, and why some permeability is normal
- The zonulin story, including why the commercial assay is disputed
- A symptom map, and the conditions that produce the same list
- What genuinely damages the barrier, graded by evidence strength
- Gut-brain and gut-hormone signaling, stated at the level the evidence supports
- Testing options including calprotectin, SCFA and stool DNA panels, with their limits
- A repair sequence, food triggers and the red flags that change the plan
The barrier, and what "leaky" actually means
The intestinal lining is one cell thick. That single layer separates roughly 30 square meters of gut contents from the bloodstream, and it has to be selective rather than sealed: nutrients cross deliberately while bacteria and large food fragments are kept out. Three structures do the work. Tight junctions, protein complexes stitching adjacent cells together, control what passes between them. A mucus layer keeps bacteria at a physical distance. And immune tissue in the gut wall, including secretory IgA, samples what arrives.
Permeability across that barrier is regulated and changes constantly, in response to meals, exercise, infection, medication and stress. So a finding of increased permeability is a description of barrier state, not a disease in itself. It is well recognized as a feature of specific conditions: untreated celiac disease, Crohn's disease and ulcerative colitis, NSAID use, alcohol-related injury and critical illness. The unsettled question is not whether the barrier can loosen. It is whether a loosened barrier in a person without one of those conditions causes the systemic symptoms attributed to it, or is simply a marker traveling alongside them.
Zonulin: the science, and the controversy
Zonulin is the protein that made leaky gut a mainstream conversation. Research led by Alessio Fasano identified it as a human regulator of tight junctions, later characterized as pre-haptoglobin-2, and showed that gliadin from wheat and certain bacteria can trigger its release, temporarily loosening the junctions. That work is genuine, and it explains a real mechanism, particularly in celiac disease.
The controversy is about measurement rather than biology. Independent laboratories analyzing the widely used commercial zonulin ELISA kits reported that the antibodies do not appear to bind pre-haptoglobin-2 specifically, and instead detect other proteins including complement and related family members. Published work by Scheffler and colleagues in 2018 and by Ajamian and colleagues in 2019 both raised this problem. The practical implication is uncomfortable but important: a serum or stool "zonulin" number from a commercial panel may not be measuring zonulin, and it should not be used on its own to confirm a barrier problem or to justify an extended treatment plan.
Zonulin describes a validated mechanism whose commercial measurement is currently unreliable, and that decisions should rest on symptoms, established diagnoses and validated tests instead.
The symptom map, and what else produces it
The symptoms attributed to intestinal permeability are real. What they are not is specific. Every row below has several possible explanations, which is why sequence matters.
| Symptom group | What people report | Also caused by |
|---|---|---|
| Digestive | Bloating that worsens through the day, alternating stool form, discomfort after meals, excess gas | IBS, SIBO, celiac disease, lactose or fructose malabsorption, pancreatic insufficiency, IBD |
| Food reactions | Reacting to foods previously tolerated, an expanding list of trigger foods | FODMAP sensitivity, histamine intolerance, celiac disease, true IgE allergy, functional gut-brain hypersensitivity |
| Systemic | Fatigue disproportionate to sleep, brain fog, low-grade aches | Iron or B12 deficiency, thyroid disease, sleep apnea, perimenopause, depression, chronic infection |
| Skin | Eczema, new rashes, rosacea flares | Atopic disease, contact dermatitis, hormonal change, dermatological conditions in their own right |
| Immune | Frequent infections, autoimmune diagnoses in the family | Autoimmune disease, which needs its own workup rather than a gut-first assumption |
Some symptoms are not candidates for a gut-permeability explanation at all and need prompt assessment: blood in the stool, unintentional weight loss, iron-deficiency anemia, symptoms that wake you at night, a change in bowel habit persisting beyond a few weeks after age 45, or a family history of bowel cancer or IBD. Celiac serology should be checked before any gluten removal, because the test becomes unreliable once gluten has been withdrawn. Where autoimmune disease is part of the picture, the autoimmune conditions page describes how that is worked up.
What genuinely damages the intestinal barrier
This is where the evidence is strongest and where most of the practical value sits. The exposures below are graded by how well established the effect is in humans.
| Exposure | What is known | Evidence |
|---|---|---|
| NSAIDs (ibuprofen, naproxen, aspirin) | Regular use measurably increases small-intestinal permeability and causes visible mucosal injury on capsule endoscopy. Among the most reliably documented causes | Strong |
| Heavy or regular alcohol intake | Directly injures the epithelium and increases permeability and endotoxin translocation in human studies | Strong |
| Untreated celiac disease | Gluten-driven immune injury flattens villi and disrupts tight junctions. Reverses on a strict gluten-free diet | Strong |
| Inflammatory bowel disease | Increased permeability is documented in Crohn's disease and ulcerative colitis and in some unaffected first-degree relatives | Strong |
| Acute gastroenteritis | Infection damages the barrier, and post-infectious IBS is a recognized outcome in a subset of people | Strong |
| Chemotherapy, burns and critical illness | Well documented barrier disruption; where the concept was first studied seriously | Strong |
| Prolonged endurance exercise in heat | Blood flow diverts away from the gut, transiently raising permeability and endotoxin markers. Usually recovers with rest and rehydration | Moderate |
| A low-fiber, ultra-processed dietary pattern | Reduced fermentable fiber lowers short-chain fatty acid production, which supports the colonic epithelium and mucus layer. Emulsifier effects are largely from animal and preclinical work | Moderate, partly mechanistic |
| Chronic psychological stress | Stress alters permeability in human experimental studies via corticotropin-releasing hormone and mast cell activation. Magnitude and clinical significance vary | Moderate |
Two things follow. Most of the strongly evidenced causes are identifiable from a careful history rather than a laboratory panel, and several are modifiable within weeks. A workup that reviews NSAID use, alcohol, recent infection and fiber intake before ordering tests resolves more cases than one starting with a stool kit. That history-first sequence is the core of the model described in what functional medicine is.
Interactive tool
Gut barrier stressor check
Tick the exposures in your history to see what is known about each one's effect on the intestinal barrier and how strong that evidence is.
Gut-brain and gut-hormone signaling
Two connections are frequently invoked to explain why gut symptoms travel with fatigue, mood change and hormonal complaints. Both are real areas of research, and both are still developing.
The gut-brain axis. Communication runs in both directions through the vagus nerve, immune signaling, and microbial metabolites including short-chain fatty acids and neurotransmitter precursors. Bidirectional signaling is established; the specific claim that a given microbiome result explains a given person's brain fog is not. In midlife women the strongest link is more prosaic: disrupted sleep and inflammation affect cognition regardless of gut findings, which is why perimenopause brain fog has several drivers.
The gut-hormone axis. A subset of gut bacteria produces beta-glucuronidase, an enzyme that deconjugates estrogens the liver has prepared for excretion, allowing some to be reabsorbed. This collection of genes is often called the estrobolome. The mechanism is documented; the leap to claiming that a stool test result explains estrogen-related symptoms in an individual woman is not supported. It is a reason to take fiber intake and bowel regularity seriously during the menopausal transition, not a diagnostic pathway. The complete guide to perimenopause covers the hormonal side of that picture.
Baseline variability is the other reason for caution. The NIH Human Microbiome Project established that healthy people carry strikingly different microbial communities, with a shared set of functions rather than a shared species list. There is no single healthy microbiome to be compared against, which limits how much weight any individual stool profile can bear.
Testing: what each option reports, and its limits
No test diagnoses leaky gut, because it is not a diagnosis. Tests do a narrower job: excluding conditions that require specific treatment, and characterizing digestive function where symptoms are unexplained.
| Test | What it measures | Where it is useful | Limitation |
|---|---|---|---|
| Celiac serology (tTG-IgA with total IgA) | Immune response to gluten | First-line in anyone with these symptoms, before any dietary change | Becomes unreliable if gluten has already been withdrawn |
| Fecal calprotectin | Neutrophil-derived protein indicating intestinal inflammation | Validated triage between IBD and IBS; a raised result warrants gastroenterology referral | Non-specific. Raised by NSAIDs, infection and some other causes |
| Lactulose-mannitol urinary recovery | Passage of two sugars across the small-intestinal barrier | The closest thing to a research standard for permeability | Mainly a research tool; poorly standardized between labs and not routinely actionable |
| Serum or stool zonulin | Marketed as a tight-junction regulator | Limited. Included in many commercial panels | Commercial assays are disputed and may not measure zonulin specifically. Should not drive treatment alone |
| Short-chain fatty acids | Fermentation output, chiefly butyrate, acetate and propionate | Supports a picture of low fermentable fiber intake | Fecal levels reflect production and absorption, so a low result is ambiguous |
| Stool DNA panels (for example GI-MAP) | PCR quantification of bacteria, fungi, parasites and markers including calprotectin | Identifying pathogens where symptoms are unexplained | Reference ranges are laboratory-specific, not consensus-derived. Findings are descriptive and easily over-interpreted |
| SIBO breath testing | Hydrogen and methane after a lactulose or glucose challenge | Where bloating is prominent and post-prandial | Interpretation criteria remain debated and false positives are common with lactulose |
| IgG food sensitivity panels | IgG antibodies to food proteins | Not recommended. Allergy bodies including the AAAAI advise against them | IgG reflects exposure, not intolerance. Leads to unnecessary and sometimes harmful restriction |
Used well, these tests narrow a differential. Used badly, they generate findings with no consensus reference range attached, and the plan that follows is driven by the printout rather than the person. Ask what a result would change before agreeing to run it.
A repair sequence that is not a 30-day protocol
The functional medicine framework here is the 5R sequence taught by the Institute for Functional Medicine: remove, replace, reinoculate, repair, rebalance. It is a useful order of operations rather than a proven treatment package, and the evidence behind each step varies considerably.
- Remove. The best-evidenced step, and the one most often skipped. Address regular NSAID use with the prescribing clinician, reduce alcohol, treat identified infections, and diagnose or exclude celiac disease and IBD. Removing an active cause outperforms every supplement discussed below.
- Replace. Support digestion only where there is a specific reason, such as documented pancreatic insufficiency. Routine enzymes in people without a deficiency have thin evidence.
- Reinoculate. Fermentable fiber from a varied plant intake has better evidence for colonic health than most probiotic capsules. Specific probiotic strains have trial evidence for specific indications, such as antibiotic-associated diarrhea, rather than for barrier repair in general.
- Repair. Glutamine, zinc carnosine and vitamin A are the usual candidates. Human evidence is limited and mostly in defined contexts such as critical illness or NSAID injury; extrapolating to healthy adults is speculative. Zinc and vitamin A both have upper limits that make casual dosing unwise.
- Rebalance. Sleep, stress physiology and meal regularity influence gut motility and permeability through established pathways, and this step is usually where durable change comes from.
Food triggers and how to reintroduce
Elimination has a role, and it is a diagnostic tool rather than a treatment. A structured trial removes a defined set of foods, commonly high-FODMAP foods where bloating dominates, for two to six weeks, and then reintroduces them one at a time with a symptom log. The reintroduction is the point: without it, the result is a permanently narrowed diet and reduced fiber diversity, which is the opposite of the goal. Any elimination running beyond six weeks without reintroduction should be reviewed, and low-FODMAP diets are best run with dietetic support.
If this pattern looks familiar, the functional medicine process page explains how a workup at Interlinked Wellness is structured, and the digestive and gut health page describes how bloating, IBS and reflux are assessed for women across Texas.
FAQ
What are the symptoms of leaky gut?
The symptoms attributed to increased intestinal permeability are bloating, discomfort after eating, alternating stool form, reacting to foods that were previously tolerated, fatigue, brain fog and skin flares. None of them is specific to the barrier. The same list is produced by IBS, SIBO, celiac disease, thyroid disease, iron deficiency and perimenopause, which is why the sequence matters: exclude the conditions with defined treatments before concluding that a permeability problem explains the picture.
Is leaky gut a real medical condition?
Increased intestinal permeability is real and measurable, and it is documented in celiac disease, inflammatory bowel disease, NSAID use, heavy alcohol intake and critical illness. "Leaky gut syndrome" as a standalone diagnosis explaining unrelated systemic symptoms is not recognized by mainstream gastroenterology, and the evidence does not currently establish that a loosened barrier causes those symptoms in otherwise healthy people. Both statements can be held at once, and a practitioner who states only one of them is giving you half the picture.
How is leaky gut tested?
There is no validated clinical test for it. The lactulose-mannitol urinary recovery test comes closest and is largely a research tool. Commercial zonulin assays are disputed, because independent analyses suggest the antibodies used may not bind zonulin specifically. What is worth testing is the differential: celiac serology before any gluten removal, fecal calprotectin to separate inflammatory from functional bowel disease, and stool or breath testing where symptoms remain unexplained. IgG food sensitivity panels are not recommended.
How long does it take to heal the gut?
It depends entirely on the cause. Stopping regular NSAIDs or reducing alcohol can improve the barrier within weeks. Celiac disease requires strict gluten avoidance with mucosal recovery over months to years. Post-infectious symptoms often settle over months. Where no cause is found, changes in fiber, sleep and stress typically take two to three months to produce a clear difference. Any protocol promising resolution in 30 days is promising more than the physiology allows.
References
- Tripathi A, et al. Proceedings of the National Academy of Sciences of the United States of America. 2009. https://pubmed.ncbi.nlm.nih.gov/19805376/
- Scheffler L, et al. Frontiers in Endocrinology. 2018. https://pubmed.ncbi.nlm.nih.gov/29459849/
- Ajamian M, et al. PloS One. 2019. https://pubmed.ncbi.nlm.nih.gov/30640940/
- Bjarnason I, et al. Gastroenterology. 2018. https://pubmed.ncbi.nlm.nih.gov/29221664/
- NIH Common Fund. National Institutes of Health. 2026. https://commonfund.nih.gov/hmp
- Human Microbiome Project Consortium. Nature. 2012. https://pubmed.ncbi.nlm.nih.gov/22699609/
- van Rheenen PF, et al. BMJ. 2010. https://pubmed.ncbi.nlm.nih.gov/20634346/
- American Academy of Allergy, Asthma & Immunology (AAAAI). AAAAI. 2026. https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/igg-food-test
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). National Institutes of Health. 2026. https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/diagnosis
About the author
Medical disclaimer. The information on this page is provided for general education and is not individualized medical advice. At Interlinked Wellness, Anna Evans, MSN, APRN, FNP-C, provides personalized care based on your health history, symptoms, concerns, and goals. An individual consultation allows Anna to evaluate your specific situation and recommend an appropriate approach to care. Reading this page alone does not establish a patient-provider relationship. If you are experiencing a medical emergency, call 911 or your local emergency services.
Join Anna on a virtual wellness journey and unlock your full potential.















